United States
Australia
Canada
Germany
India
Ireland
Japan
Mexico
New Zealand
Philippines
South Africa
United Kingdom
Citeline Podcasts
From Norstella
Business
Generics Bulletin Podcasts
by Norstella
Chart positions today · Brazil
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Japan charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like Generics Bulletin Podcasts, try…
Pink Sheet Podcasts
From Norstella
Behavioral Threat Analysis Center – Beyond the Bulletin
Similar topics: bulletin and beyond
Discover IP
Also in Business
Record Deep
Similar topics: record
The Manila Bulletin Daily News Rundown
Similar topics: bulletin
Ranking history · Brazil
No ranking history for this show in Brazil over the last 7 days.
Latest episodes
-
Off-Patent, On Record: Unlocking The Value Of Biosimilars Beyond Savings With IGBA’s Ana Gaunt
October 19, 2026 · 27 minIn the latest episode of Off-Patent, On Record, Generics Bulletin’s senior reporter Urtė Fultinavičiūtė talks to the International Generic and Biosimilar medicines Association’s secretary general Ana Gaunt to mark the start of Global…
-
Off-Patent, On Record: Navigating The Financial Strategy Behind Litigation With Sandoz’s Julia Pike
October 6, 2026 · 24 minIn the third episode of Off-Patent, On Record, Generics Bulletin’s senior reporter Urtė Fultinavičiūtė is joined by Sandoz’s head of IP Julia Pike to analyze the European intellectual property system, how it compares to the US, and the…
-
The Generics Bulletin Podcast: Discussing Sandoz’s Strategy Updates As It Prepares For A Biosimilars Boom
September 9, 2026 · 14 minOn September 8, Sandoz revealed a slew of strategy updates and forecasts at a capital markets day at the London Stock Exchange. Generics Bulletin editor Dave Wallace was there, and discusses the key details with deputy editor Dean Rudge.
-
Off-Patent, On Record: A Story Of Patients Fighting For Accessible Cystic Fibrosis Treatment
September 2, 2026 · 23 minIn the second episode of Off-Patent, On Record, Generics Bulletin’s senior reporter Urtė Fultinavičiūtė hears how patients with cystic fibrosis travelled to Bangladesh to collect generic version of Vertex’s highly inaccessible Trikafta…
-
Generic Bulletin Trailer
August 19, 2026 · 1 min
Show 5 more episodesShow fewer episodes
-
Off-Patent, On Record: View Through The Journalist's Lens With Generics Bulletin's Dave Wallace
August 4, 2026 · 24 minGenerics Bulletin’s senior reporter Urtė Fultinavičiūtė launches a new interview podcast series “Off-Patent, On Record.” In the inaugural episode, Urtė is joined by Dave Wallace, executive editor at Generics Bulletin, who has been covering…
-
The Next Era Of Oncology Biosimilars
July 22, 2026 · 17 minOncology biosimilars have already helped expand access to established biologic treatments while supporting more sustainable healthcare spending. As the market moves towards increasingly complex therapies, however, identifying viable…
-
The Generics Bulletin Podcast: Summer Conferences
July 20, 2026 · 22 minGenerics Bulletin's editorial team discusses the recent Medicines for Europe legal and annual conferences, attended by executive editor Dave Wallace, as well as the Medicines UK conference attended by reporter Anabel Costa-Ferreira.
-
The Generics Bulletin Podcast: Probing The Patent Monopoly With I-MAK’s Tahir Amin
June 18, 2026 · 29 minThe Generics Bulletin Podcast: Probing The Patent Monopoly With I-MAK’s Tahir Amin Description: Generics Bulletin senior reporter Urtė Fultinavičiūtė talks to Tahir Amin, co-founder and CEO of I-MAK, about the current intellectual…
-
The Generics Bulletin Podcast: Biosimilars Conference Report And Big M&A Deals
May 14, 2026 · 27 minGenerics Bulletin's editorial team discusses the recent Medicines for Europe biosimilars conference, attended by deputy editor Dean Rudge; while editor Dave Wallace talks about the latest big deals in biosimilars and what is behind them.
About the show
The Generics Bulletin Podcast takes you inside the trends and decisions driving the global generics and biosimilars industry. Created for industry professionals, episodes published bi-monthly feature specialist reporters and expert voices unpacking regulatory shifts, pricing pressures, market access and competitive dynamics – alongside on-the-ground insights from key industry conferences. Visit us at https://insights.citeline.com/generics-bulletin to sign up for newsletters and stay ahead. For any podcast feedback or queries, you can now reach us at podcasts@norstella.com.